本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Oric Pharmaceuticals Inc.

10.55
+0.06000.57%
成交量:43.59萬
成交額:461.94萬
市值:8.99億
市盈率:-5.61
高:10.86
開:10.32
低:10.20
收:10.49
資料載入中...
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

SEC問詢函

Form CORRESP - Correspondence
2024/01/30

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/22

重要事件披露

Form 8-K - Current report